Daniel Levangie is an experienced executive with senior operating experience in the field of medical devices and in vitro diagnostics. Mr. Levangie is co-founder and Managing Partner of ATON Partners, LLC, and Chairman of Cerevasc, LLC, a Boston based company focused on the development of the eShunt™ Cerebral Spinal Fluid (CSF) device for the treatment of communicating hydrocephalus.
Most recently, Mr. Levangie was Chief Executive Officer of Dune Medical Devices and co-founder and Managing Partner of Constitution Medical Investors, Inc. (CMI)
Mr. Levangie is a member of the Board of Directors of Exact Sciences, Inc., Liposcience, Inc., Dune Medical Devices, LTD. and is Lead Director of Insulet Corporation. Mr. Levangie, a graduate of the College of Pharmacy of Northeastern University in Boston, is a member of the Advisory Board of the Barnett Institute of Northeastern University and is a trustee of Excel Charter School.